Martin Fergie

Martin Fergie, Chief Executive Officer of Spotlight Pathology

Martin Fergie is the Co-Founder and Chief Executive Officer of Spotlight Pathology, a spin-out company from the University of Manchester that is developing AI-powered tools to help streamline the diagnosis of blood cancers.245 He has over 15 years of experience developing AI algorithms for image analysis in industry and academia.24

Key Facts about Martin Fergie:

• Current Roles:

  • Chief Executive Officer, Spotlight Pathology Ltd (since October 2021)34
  • Non-executive Director, VREvo Ltd (since November 2021)3
  • Lecturer in Healthcare Sciences, The University of Manchester (since 2017)23

• Previous Experience:

  • Chief Technology Officer, DigitalBridge (now Fixtuur) (2012-2017)23
  • PhD in Machine Learning for 3D Human Pose Estimation, The University of Manchester (2008-2012)3

• Education:

  • The University of Manchester (2008-2012, 2004-2008)1

Fergie is developing a set of AI tools at Spotlight Pathology with three key aims5:

1. Reducing the time from biopsy to diagnosis and treatment to improve patient outcomes
2. Increasing the diagnostic capacity of pathology services
3. Improving the standardization and objectivity of diagnoses

The company's AI algorithm can interpret digitized tissue samples to provide a lymphoma diagnosis and type.5 Spotlight Pathology is targeting a 2025 launch for its tools and is currently in the R&D stage, forming research collaborations with hospitals in the UK and abroad.5